Gabapentin Suspension
Product Images NDC 59762-5050

7 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 59762-5050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cockcroft And Gault Equation (Image 01)

Cockcroft And Gault Equation (Image 01)
An illustration depicting the formula for creatinine clearance (CLCr) calculation using age, weight, serum creatinine levels, and a gender adjustment factor for female patients.*
FDA Label Image

Gabapentin Structural Formula (Image 02)

Gabapentin Structural Formula (Image 02)
Chemical structure diagram of gabapentin, showing its molecular framework with a cyclohexane ring and functional groups including an amino group and a carboxyl group.*
FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Image 03)

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Image 03)
A line graph showing mean pain scores over an 8-week period comparing placebo and gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score trend, while placebo remains relatively stable.*
FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Image 04)

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Image 04)
A line graph showing the mean pain score over 7 weeks comparing placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The timeline is divided into a 3-week dose titration period followed by a 4-week fixed dose period. Pain scores decrease more with gabapentin doses compared to placebo over time.*
FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Image 05)

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Image 05)
A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' compares response rates in two studies. Study 1 shows 12% response for placebo (PBO) and 29% for gabapentin 3600 mg (GBP 3600). Study 2 shows 14% for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated by p-values less than 0.01 and 0.001.*
FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 06)

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 06)
A scatter plot showing the percentage difference by daily dose (mg) of gabapentin 250 mg/5mL oral suspension. The chart compares results from three studies (a, b, and c) across doses ranging from 600 to 1800 mg daily. Differences range from approximately 5% to 18%. Black squares represent Study a, gray squares Study b, and white squares Study c.*
FDA Label Image

Gabapentin Oral Solution 250 mg Per 5 mLcarton Label (Image 07)

Gabapentin Oral Solution 250 mg Per 5 mLcarton Label (Image 07)
Packaging label for Gabapentin oral solution 250 mg per 5 mL, a Greenstone brand suspension. The label includes dosage strength, volume (470 mL), storage instructions, barcode, and distributor information for Greenstone LLC, Morgantown, WV. The label advises dispensing with a medication guide and includes dosage and use information to see the prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.